Adoption of Immune Checkpoint Inhibitors and Patterns of Care at the End of Life.

JCO Oncology Practice
Fauzia RiazCary P Gross

Abstract

As immune checkpoint inhibitors (ICIs) have transformed the care of patients with cancer, it is unclear whether treatment at the end of life (EOL) has changed. Because aggressive therapy at the EOL is associated with increased costs and patient distress, we explored the association between the Food and Drug Administration (FDA) approvals of ICIs and treatment patterns at the EOL. We conducted a retrospective, observational study using patient-level data from a nationwide electronic health record-derived database. Patients had advanced melanoma, non-small-cell lung cancer (NSCLC; cancer types with an ICI indication), or microsatellite stable (MSS) colon cancer (a cancer type without an ICI indication) and died between 2013 and 2017. We calculated annual proportions of decedents who received systemic cancer therapy in the final 30 days of life, using logistic regression to model the association between the post-ICI FDA approval time and use of systemic therapy at the EOL, adjusting for patient characteristics. We assessed the use of chemotherapy or targeted/biologic therapies at the EOL, before and after FDA approval of ICIs using Pearson chi-square test. There was an increase in use of EOL systemic cancer therapy in the post-ICI...Continue Reading

References

Apr 21, 1984·Lancet·R L KaneS Kaplan
Feb 7, 1998·Medical Care·A ElixhauserR M Coffey
Mar 15, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Craig C EarleSusan Block
Apr 16, 2003·Annals of Internal Medicine·Ezekiel J EmanuelArlene S Ash
Dec 9, 2004·JAMA : the Journal of the American Medical Association·Peter B BachColin B Begg
Oct 9, 2008·JAMA : the Journal of the American Medical Association·Alexi A WrightHolly G Prigerson
May 27, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S KaoD Adams
Jul 9, 2010·Journal of the American College of Surgeons·Arden M MorrisJohn D Birkmeyer
Sep 8, 2010·The New England Journal of Medicine·Jennifer S TemelThomas J Lynch
Feb 9, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hsien SeowCraig Earle
Mar 16, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thi H HoCraig C Earle
Dec 29, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Joseph A GreerJennifer S Temel
Apr 12, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lowell E SchnipperDana S Wollins
Nov 28, 2013·Nature Reviews. Clinical Oncology·Shaheen A KhanIrene J Higginson
Jul 26, 2014·Cancer Treatment Reviews·David McDermottCharles M Balch
Mar 21, 2015·BMC Palliative Care·Hee Seung LeeSooHyeon Lee
Jun 2, 2015·The New England Journal of Medicine·James LarkinJedd D Wolchok
Jul 24, 2015·JAMA Oncology·Holly G PrigersonPaul K Maciejewski
Aug 25, 2015·Patient Education and Counseling·Douglas W MaynardToby C Campbell
Jan 20, 2016·Journal of Geriatric Oncology·Shi-Yi WangCary P Gross
Jan 20, 2016·JAMA : the Journal of the American Medical Association·Alexi A WrightMary B Landrum
Jul 4, 2016·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·David HuiEduardo Bruera
Jan 20, 2018·Asia-Pacific Journal of Clinical Oncology·Johnathan ManChee Khoon Lee
May 15, 2018·Health Services Research·Melissa D CurtisAmy P Abernethy
Oct 12, 2018·Seminars in Oncology·Tito Fojo
Mar 19, 2019·Journal of Oncology Practice·Joshua KrautNeal J Meropol
May 30, 2019·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Penny FangGrace L Smith

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Handbook of Clinical Neurology
Johan A F KoekkoekMartin J B Taphoorn
Canadian Respiratory Journal : Journal of the Canadian Thoracic Society
Benjamin TamAlison Fox-Robichaud
Academic Medicine : Journal of the Association of American Medical Colleges
David E Weissman, Susan D Block
© 2021 Meta ULC. All rights reserved